Inhaled Mannitol (Bronchitol) for Cystic Fibrosis
Date: May 31, 2021
Issue #:
1625Summary:
The FDA has approved mannitol powder for oral
inhalation (Bronchitol– Chiesi) as add-on maintenance
treatment to improve pulmonary function in adults with
cystic fibrosis (CF). This product has been available in
Europe for the same indication since 2012. Another
formulation of mannitol inhalation powder(Aridol)
is approved in the US for assessment of bronchial
hyperresponsiveness.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Source Type: research
More News: Cystic Fibrosis | Drugs & Pharmacology